Management of Cardiovascular Medicines Used at the Regional Diagnostic and Treatment Center of the Western Region of Mongolia

Authors

  • Dulmaa Lkhagvasuren Department of Pharmaceutical Chemistry and Pharmacognosy of School of Pharmacy, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Yerkyebulan Mukhtar Department of Epidemiology and Biostatistics of School of Public Health, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Erdenetuya Myagmarsuren Department of Clinical Pharmacy and Management of School of Pharmacy, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Enkhjargal Dorjbal Department of Pharmaceutical Chemistry and Pharmacognosy of School of Pharmacy, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia

DOI:

https://doi.org/10.21276/apjhs.2021.8.2.08

Keywords:

Cardiovascular, Medicine’s management, Pharmacoeconomics

Abstract

As cardiovascular diseases are the major global health problem, the management of cardiovascular medicines (CVMs) should not be out of attention. We aimed to identify CVMs needing strict management control, used in 2017 and 2018 to investigate if there was a possibility to make savings in the expenditure for CVMs if the proper management was done regarding Class A medicines at the Regional Diagnostic Treatment Center of Khovd aimag in 2018. Aggregate data methods, Always, Better and Control (ABC), Vital, Essential and Non-essential (VEN), and ABC-VEN matrix analyses were used to identify the categories of CVMs, included in the Essential Medicine List of Mongolia for the year 2017 and 2018. Class A medicines represented 23.81% and 30.43% of the total CVMs and consumed the largest proportion of the total budgets at 73% and 71% in 2017 and 2018, respectively. The Category I, which requires strict management control, contains the majority (an average of 59%) of total CVMs and amounting for an average of 78.67% of total expenditures in 2017 and 2018. We conclude that the Regional Diagnostic and Treatment Center could have saved a total of 6,646,500 MNT if the proper management regarding Class A medicines was done in 2018 based on the results of ABC, VEN, and ABC-VEN matrix analyses of 2017.

Downloads

Download data is not yet available.

Downloads

Published

2021-04-13

How to Cite

Lkhagvasuren, D., Mukhtar, Y., Myagmarsuren, E., & Dorjbal, E. (2021). Management of Cardiovascular Medicines Used at the Regional Diagnostic and Treatment Center of the Western Region of Mongolia. Asian Pacific Journal of Health Sciences, 8(2), 38–44. https://doi.org/10.21276/apjhs.2021.8.2.08